Zobrazeno 1 - 10
of 162
pro vyhledávání: '"F.F.H. Rutten"'
Autor:
F.F.H. Rutten, Richard Berges, Christopher R. Chapple, Marc A. Koopmanschap, N.J.A. van Exel, Joseph McDonnell
Publikováno v:
European Urology, 49, 92-102. Elsevier
Objective To determine the medical consumption and associated treatment costs of patients with LUTS suggestive of BPH. Methods A prospective, cross-sectional, observational survey in six European countries: France, Germany, Italy, Poland, Spain and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af92b5b6b986d0495d24c1010978d57
https://pure.eur.nl/en/publications/8fa31ab6-59a5-4e39-9f07-477b2bf23a10
https://pure.eur.nl/en/publications/8fa31ab6-59a5-4e39-9f07-477b2bf23a10
Publikováno v:
Journal of Pediatric Surgery. 35:588-592
Background/Purpose: Technological developments have revolutionized both diagnosis and treatment in neonatal surgery. However, it has been increasingly recognized that financial resources might become insufficient to provide all the medical care that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f294cd483f9709bc5029148d70da7d
https://doi.org/10.1053/jpsu.2000.0350588
https://doi.org/10.1053/jpsu.2000.0350588
Publikováno v:
British Journal of Haematology. 100:629-636
We conducted a prospective, randomized, multicentre clinical trial comparing the effects and costs of GM-CSF as an adjunct to intensive chemotherapy in elderly patients with acute myeloid leukaemia (AML). The patients were randomized to either daunom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03f164e1403492188eba6292fafb17e5
https://doi.org/10.1046/j.1365-2141.1998.00635.x
https://doi.org/10.1046/j.1365-2141.1998.00635.x
Autor:
P. J. van Enckevort, Gouke J. Bonsel, EM TenVergert, F.F.H. Rutten, W J de Boer, Marc A. Koopmanschap, Maiwenn Al, W. van der Bij, A. Geertsma
Publikováno v:
International journal of technology assessment in health care, 14(2), 344-356. Cambridge University Press
The costs, effects, and cost-effectiveness of the Dutch Lung Transplantation program were assessed. The results show that lung transplantation is a very costly intervention that improves survival and quality of life. Costs per life-year and per QALY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a89b52a583851b69a7b662d6be954d1
https://doi.org/10.1017/s0266462300012307
https://doi.org/10.1017/s0266462300012307
Publikováno v:
PharmacoEconomics. 10:23-35
High dosage chemo- or radiotherapy followed by the administration of autologous bone marrow-derived stem cells [i.e. autologous bone marrow transplantation (ABMT)] is an established protocol for treating acute myeloid leukaemia and malignant lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42239cf4f7a4f570fe7b7974a0724a03
https://doi.org/10.2165/00019053-199610010-00004
https://doi.org/10.2165/00019053-199610010-00004
Publikováno v:
Computer Methods and Programs in Biomedicine. 48:45-52
In this paper we discuss an approach to classifying evaluative studies of automated information systems in health care. Selected literature (76 studies) is classified according to the type of automated information system (based on relationship to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389787b2f8009af0db6d319bf3677159
https://doi.org/10.1016/0169-2607(95)01659-h
https://doi.org/10.1016/0169-2607(95)01659-h
Publikováno v:
European Journal of Cancer. 30:111-117
In the economic evaluation (EE) of technologies in cancer treatment at least three endpoints are relevant: costs, survival and quality of life (QoL). This article is focused on QoL. EE requires the use of generic and valuation QoL instruments at a di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ddd6d3ca245ca75cb0e1001da2c17b
https://doi.org/10.1016/s0959-8049(05)80030-9
https://doi.org/10.1016/s0959-8049(05)80030-9
Publikováno v:
European Journal of Cancer. 29:S10-S14
A recent extension of clinical evaluation is “economic evaluation”, which seeks to characterise each relevant alternative health care strategy in terms of a summary measure incorporating the costs and benefits of such strategies. In an economic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b28de8e1b2c7d65f4421c29ca337f32
https://doi.org/10.1016/0959-8049(93)90610-r
https://doi.org/10.1016/0959-8049(93)90610-r
Publikováno v:
European Journal of Cancer. 30:457-459
In a retrospective study, we calculated the treatment costs of 26 patients, who received either high dose melphalan combined with granulocyte colony-stimulating factor (G-CSF; filgrastim)(n = 7) or without G-CSF (n = 11) or alternatively, peripheral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3ea500df886a24ae71abbb0cbd9c01
https://doi.org/10.1016/0959-8049(94)90418-9
https://doi.org/10.1016/0959-8049(94)90418-9
Autor:
Joseph McDonnell, Esther T. Kok, Jan Busschbach, F.F.H. Rutten, Marc A. Koopmanschap, Elly A. Stolk, J. van Exel
Publikováno v:
European urology. 39
Given the ageing of western populations, the cost burden associated with the treatment of LUTS suggestive of BPO will increase substantially over the next few decades. Therefore, from the economic perspective, the primary objective of the Triumph pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d606a09ccbd25147179ec5e176a8c1c
https://pubmed.ncbi.nlm.nih.gov/11275741
https://pubmed.ncbi.nlm.nih.gov/11275741